Table 2 Clinical characteristics of patients with localized versus metastatic ASPS
From: Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study
Variable | Localized ASPS (n = 34) | Metastatic ASPS (n = 86) | p value | ||
|---|---|---|---|---|---|
N | % | N | % | ||
Age | Â | Â | Â | Â | 0.023 |
  ≤ 25 years | 20 | 40% | 30 | 60% |  |
  > 25 years | 14 | 20% | 56 | 80% |  |
Sex | Â | Â | Â | Â | 0.289 |
 Male | 9 | 21% | 33 | 79% |  |
 Female | 25 | 32% | 53 | 68% |  |
Tumor site | Â | Â | Â | Â | 0.520 |
 Lower extremity | 19 | 26% | 55 | 74% |  |
 Upper extremity | 5 | 46% | 6 | 55% |  |
 Trunk | 10 | 29% | 24 | 71% |  |
 Head and neck | 0 | 0% | 1 | 100% |  |
Tumor depth | Â | Â | Â | Â | 0.002 |
 Superficial | 6 | 86% | 1 | 14% |  |
 Deep | 28 | 25% | 85 | 75% |  |
Tumor size |  |  |  |  |  < 0.001 |
 ≤ 5 cm | 16 | 59% | 11 | 41% |  |
 > 5 cm, ≤ 10 cm | 13 | 19% | 54 | 81% |  |
 > 10 cm | 5 | 19% | 21 | 81% |  |